Guggenheim lowered the firm’s price target on Endava (DAVA) to $28 from $40 and keeps a Buy rating on the shares. The firm expects Endava management to reiterate its current FY25 outlook despite the elevated uncertainty of the current macroeconomic environment, but is lowering its price target given a broader sector re-rating, the analyst tells investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
